Finding Biopharma Licensing and Collaboration Partners

Be the first to review this product

Availability: In stock

$1,495.00

Quick Overview

Practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation .

Finding Biopharma Licensing and Collaboration Partners
Publication date Apr 2015
Publisher Current Partnering
Number of pages 172
Report edition 3
Product code CP2010
ISBN n/a
Product type Research report
Available formats PDF, CD-ROM

* Required Fields

$1,495.00

Current Partnering’s Finding Biopharma Licensing and Collaboration Partners provides a comprehensive overview of all the steps required to identify and secure potential partnering opportunities  either for an in-licensing or out-licensing activity.

 

The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation.

 

In addition, the report provides a detailed overview of the activities a business development executive and a company should be undertaking to build and maintain an extensive contact network, and to become partner of choice, respectively.

 

The report is structured to take the reader step by step through the process of finding and securing partners. However, each chapter is also acts an easy access reference to the particular activity. The report contains numerous checklists and summaries of the contents of key documents required during the partnering process. The report is also provides numerous insights drawn from extensive direct industry experience and knowledge of the author and others.

 

The report provides numerous examples of actual information sources and actual materials utilized by biopharma companies during their partnering efforts, allowing the reader to act on the contents of the report in order to improve their own partnering processes and activities.

 

Chapter 2 provides an overview of the partnering process and highlights the differences between an in-licensing and out-licensing activity.

 

Chapter 3 provides a detailed review of the processes required for the successful identification of in-licensing opportunities. From defining the ideal opportunity and marketing partnering needs, through to desk research and short listing opportunities, the chapter takes the reader through the steps in detail and provides tips on how to overcome the most common issues.

 

Chapter 4 looks at the same issue from the perspective of a company seeking out-licensing partners for its product or technology. The chapter covers the same issues of ideal partner and marketing partnering opportunities, through to desk research and short listing partners. The chapter takes the reader through each step in detail and provides tips on how to overcome the most common problems confronted by those seeking to out-license. The chapter finishes by providing an overview of how to manage multiple parallel discussions with partner companies and the possibility of the partner being an alternative to venture capital funding.

 

Chapter 5 then looks in detail at the importance of building and maintaining a network of contacts. From discussing how to build and network through to tips on how to network successfully, the chapter provides a comprehensive ‘how to’ guide to networking.

 

The report then progresses in chapter 6 to the packaging of your offering for consideration by prospective partners. From marketing your company and partnering interests through to the preparation of marketing materials, non confidential and confidential dossier and supporting materials, the chapter provides detailed and practical advice on what and how to prepare print and electronic materials in preparation for making contact.

 

Chapter 7 then goes onto the discuss how to make contact with potential partners in a professional and effective way. The chapter provides an overview of the contact process, guidelines on how to make contact with bigpharma and smaller companies, tips on how to make success contact, managing contacts and then finishes with a detailed overview of the sources of contact information available to the business developer. The chapter also discusses the important role of partnering meetings in providing an effective and efficient means of initiating multiple discussions with potential partners.

 

Becoming ‘partner of choice’ is discussed in detail in chapter 8. The chapter discusses why being partner of choice is important and provides details on the characteristics of companies regarded as partner of choice, and practical advice on how to become partner of choice in your company’s chosen areas of interest.

 

Finally, chapter 9 provides easy to use checklists for a number of the processes discussed in the report, allowing the reader to implement best practice into their business development activities straight away.

 

In summary, this report seeks to provide the business developer with the knowledge and tools to become more effective in finding and securing partners and opportunities. The report will provide an excellent learning tool for those new to business development and allow more experienced practitioners the opportunity to learn, improve and implement best practice into their business development roles.

 

Report scope

 

Practical Guide to Finding Partners provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity.

 

The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation.

 

Finding Biopharma Licensing and Collaboration Partners includes:

 

  • Overview of the partnering process and highlights the differences between an in-licensing and out-licensing activity
  • Detailed review of the processes required for the successful identification of in-licensing opportunities and out-licensing partners
  • Importance of building and maintaining a network of contacts
  • Packaging of your offering for consideration by prospective partners
  • How to make contact with potential partners in a professional and effective way
  • Characteristics of companies regarded as partner of choice, and practical advice on how to become partner of choice in your company’s chosen areas of interest
  • Easy to use checklists for a number of the processes discussed in the report

Finding Biopharma Licensing and Collaboration Partners provides the reader with a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity.

 

Comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity

 

Takes reader through the practical steps required to prepare:

  • For partnering
  • Prepare supporting materials
  • Identify and shortlist potential partners and opportunities
  • Identify and contact the right person in the partner company       

 

Provides detailed overview of activities a business development executive and a company should be undertaking to:

  • Build and maintain an extensive contact network
  • Become partner of choice

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Overview of the partnering process

 

2.1. Introduction

2.2. The general partnering process

2.3. Unique aspects of in-licensing

2.3.1. The in-licensing action plan

2.4. Unique aspects of out-licensing

2.4.1. The out-licensing action plan

 

Chapter 3 – Identifying in-licensing opportunities

                          

3.1. Introduction

3.2. Defining the ideal opportunity

3.2.1. Creating the ‘ideal’ opportunity profile

3.2.2. Obtaining buy-in from internal stakeholders

3.3. Desk research

3.3.1. Defining detailed search criteria

Therapy focus

Technology focus

Development phase

Geographic focus

Technology origins

Risk    

Sales potential 

Product performance

Potential deal terms

Potential availability

Fit with existing portfolio          

3.3.2. Everything is available if the price is right

3.3.3. Conducting desk research          

3.3.4. Sources of partnering opportunities

3.3.5. Using the Internet

3.3.6. Using new media for online networking

3.3.7. Using consultants

3.4. Marketing partnering needs to generate interest

3.5. Common issues in identifying opportunities

3.6. Primary, secondary and tertiary opportunities

3.6.1. From long list to short list

3.6.2. Using Excel to sort opportunities versus search criteria

3.6.3. Final internal review

3.7. The role of multiple parallel discussions

 

Chapter 4 – Identifying partners

 

4.1. Introduction           

4.2. Timing      

4.3. Defining the ideal partner   

4.3.1. Creating the ‘ideal’ partner profile

4.3.2. The partnering world consists of more than bigpharma

4.3.3. Obtaining buy-in from internal stakeholders

4.4. Defining target deal types and terms

4.5. Readiness to partner

4.6. Desk research to identify the ideal partner

4.6.1. Defining search criteria

4.6.2. Conducting desk research

4.6.3. Sources of partners

4.6.4. Using the Internet

4.6.5. Using consultants

4.7. Marketing partnering opportunities to generate interest

4.8. Common issues in identifying partners

4.9. Prioritizing target partners 

4.9.1. From long list to short list           

4.9.2. Using Excel to sort partner companies versus search criteria

4.9.3. Final internal review

4.10. The role of multiple parallel discussions

4.11. Partners as alternative investors to VCs

 

Chapter 5 - Building and maintaining a partnering network

                                      

5.1. Introduction

5.2. Strategy and planning

5.3. Common concerns about networking and how to overcome

5.4. The inverse pyramid effect

5.5. Raising awareness

5.6. Building a contact network 

5.7. Top tips for successful networking 

5.8. Do potential partners know how to make contact?

5.9. The role of regular networking

5.10. The role of partnering meetings

5.11. Maintaining the network when back in the office

5.12. Email newsletters

5.13. Online networks  

5.14. Other network building techniques

 

Chapter 6 – Packaging your offering

 

6.1. Introduction

6.2. Packaging your company as the perfect partner

6.2.1. Customized corporate presentation

6.2.2. Typical contents of an in-licensing corporate presentation

6.3. Packaging your partnering opportunity

6.3.1. The pitch document

6.3.2. Non-confidential information        

6.3.3. What do online submission forms suggest?

6.3.4. Confidential dossier        

6.3.5. Presentation materials    

6.3.6. Supporting information    

6.3.7. Electronic information transfer    

6.4. Confidential disclosure agreements (CDA)

6.4.1. From the perspective of the licensor

6.4.2. From the perspective of the licensee

6.4.3. What should a CDA include?

6.5. Option and evaluation agreements 

6.6. Pitching your partnering interests at partnering meetings

6.6.1. Pre-event preparation     

6.6.2. During the event 

6.6.3. Post event follow-up

6.7. Meetings, meetings, meetings       

6.8. What other information you should have ready?

6.8.1. Draft deal terms 

6.8.2. Data room          

6.8.3. Expertise available for Q&A

 

Chapter 7 – Making contact

 

7.1. Introduction

7.2. Overview of the contact process    

7.3. The importance of making a good first impression

7.4. How to make contact with bigpharma         

7.4.1. How to make contact      

7.4.2. The right contact

7.4.3. How a partnering opportunity is assessed

7.4.4. Timings, culture and logistics     

7.4.5. Types of people  

7.4.6. Contact processes         

7.5. How to make contact with a smaller biopharma/technology company

7.5.1. How to make contact      

7.5.2. The right contact

7.5.3. How a partnering opportunity is assessed

7.5.4. Timings, culture and logistics     

7.5.5. Types of people  

7.5.6. Contact processes         

7.6. Tips for successful contact

7.7. Managing contacts

7.7.1. The contact record         

7.7.2. Contact management software    

7.7.3. Managing interest           

7.7.4. Importance of recording rejections          

7.8. Sources of contact information       

7.8.1. Primary contact sources 

Personal network         

Company websites       

Databases       

Conferences    

Industry press and media

Regulatory filings

Consultants

Unsolicited contact      

7.8.2. Online submission forms

 

Chapter 8 – Becoming partner of choice

 

8.1. Introduction           

8.2. What is ‘partner of choice’?

8.3. Characteristics of partner of choice

8.3.1. Internal buy-in to alliances          

8.3.2. Well resourced alliance team      

8.3.3. Ability to move fast         

8.3.4. Mutual respect and open communication 

8.3.5. Excellent track record     

8.3.6. Deal term flexibility         

8.3.7. Alliance management skills         

8.3.8. Value creation    

8.3.9. Quids     

8.4. Becoming partner of choice           

8.4.1. Marketing           

8.4.2. Track record      

8.4.3. Partner focus     

8.4.4. Effective, responsive and transparent      

8.4.5. Identify and resolve weaknesses

 

Chapter 9 - Resource Center

 

9.1. Resources

9.2. Checklists 

Checklist 1: Partnering process

Checklist 2: Finding opportunities

Checklist 3: Finding partners

Checklist 4: Packaging the partnering offering

 

Appendices    

 

Appendix 1 – Glossary of terms used in this report

Appendix 2 – Top fifty biopharma and recent deal activity

 

About Wildwood Ventures         

Current Partnering       

Current Agreements     

Current Reports           

Recent titles from CurrentPartnering

Order Form – Reports  

Order Form – Therapy Reports 

 

Table of figures

 

Figure 1: Overview of the partnering process    

Figure 2: Unique steps in the in-licensing process

Figure 3: In-licensing action plan          

Figure 4: Unique steps in the out-licensing process

Figure 5: Out-licensing action plan       

Figure 6: The ‘ideal’ opportunity profile

Figure 7: Search criteria spreadsheet   

Figure 8: Key sources of partnering opportunities

Figure 9: Corporate partnering opportunity databases

Figure 10: Academic partnering opportunity databases

Figure 11: Key online partnering networks

Figure 12: Sample qualitative scoring system for short listing opportunities

Figure 13: Sample Excel spreadsheet used to score long list partnering opportunities

Figure 14: Deal timing – the relationship of deal value and risk

Figure 15: Optimum timing for out-licensing

Figure 16: Deal types for consideration by licensors

Figure 17: Defining deal terms

Figure 18: Partner search criteria spreadsheet

Figure 19: Key sources of partner companies

Figure 20: Corporate partnering databases

Figure 21: Sample qualitative scoring system for short listing partners

Figure 22: Sample Excel spreadsheet used to score long list partnering opportunities

Figure 23: Forms of funding from partner companies     

Figure 24: The contact inverse pyramid

Figure 25: Top tips for successful networking   

Figure 26: Major networking clubs in biopharma

Figure 27: Example regional networking clubs in biopharma

Figure 28: Example major networking events operated by network clubs

Figure 29: Key partnering events - International

Figure 30: Major biopharma conferences with networking emphasis       

Figure 31: Amgen’s Online Outreach newsletter

Figure 32: Raucon’s The Pharma Business Developer  

Figure 33: CurrentPartnering’s Dealmakers Update       

Figure 34: Leading online networking tools        

Figure 35: Key online partnering networks for life sciences

Figure 36: Contents of typical corporate presentation    

Figure 37: Online submission evaluation requirements  

Figure 38: Submission form summary from Pfizer website         

Figure 39: Tips on making a good first impression        

Figure 40: Bigpharma partnering opportunity assessment process         

Figure 41: Characteristics of partner of choice  

Figure 42: Partnering resource finder

Figure 43: Bigpharma – top 50 by pharma revenues and deal signed

Pricing options

  • $1,495: single-user
  • $2,245: multi-user
  • $4,485: single site license
  • $7,475: global site license

 

A full explanation of license type definitions can be found here.

 

An additional $500 per copy will be added for full print and CD-ROM.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

You may also be interested in the following product(s)

Top 50 Big Biotech Partnering and M&A Deal Trends

Top 50 Big Biotech Partnering and M&A Deal Trends

$2,495.00
     

Product Tags

Other people marked this product with these tags:

Use spaces to separate tags. Use single quotes (') for phrases.

© 2015 Wildwood Ventures Ltd.